Artrya’s coronary diagnostic product has been given regulatory approval for use in the UK after being knocked back by the US Food and Drug Administration five months ago.

Artrya’s coronary diagnostic product has been given regulatory approval for use in the UK after being knocked back by the US Food and Drug Administration five months ago.